P140K methylguanine-DNA-methyltransferase mutant CD34+ cells

DB17093ExperimentalCell transplant therapies

P140K methylguanine-DNA-methyltransferase mutant CD34+ cells: Overview.

Which companies are running trials of P140K methylguanine-DNA-methyltransferase mutant CD34+ cells, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In